Document is current
Any future updates will be listed below
-
Authors
Demkes, Evelyne
Cervera-Barea, Aina https://orcid.org/0000-0003-3944-9756
Ebner-Peking, Patricia
Wolf, Martin
Hochmann, Sarah
Scheren, Amy S.
Bijsterveld, Mayke
van Oostveen, C. Marlies
Jansen, Marlijn
Visser, Joyce
Triebert, Wiebke
Halloin, Caroline
Dobbe, Johannes G. G.
de Vos, Judith
Schürz, Melanie
Danmayr, Joachim
Aalders, Maurice C. G.
Boink, Gerard J. J.
Neef, Klaus
Strunk, Dirk
Zweigerdt, Robert
de Jager, Saskia C. A.
Sluijter, Joost P. G.
- License Information
-
More Information
Article History
Received: 21 July 2024
Accepted: 20 January 2025
First Online: 13 March 2025
Declarations
:
: None competing interests to declare related to this manuscript. Additional relationships from D.S. not related to this article include funding shared with ACCANIS Biotech for the development of mRNA therapies and consultancy fees from Advantage Therapeutics and AOP Health. Other relationships from G.J.J.B. not related to this article include equity ownership and role as CEO at PacingCure, a company envisioned to provide precision gene therapies for cardiac disease.
: The authors did not use generative AI or AI-assisted technologies in the development of this manuscript.
: No human studies were carried out by the authors for this article.
